40 related articles for article (PubMed ID: 10675732)
1. delta-Opioid receptor agonists produce antinociception and [35S]GTPgammaS binding in mu receptor knockout mice.
Hosohata Y; Vanderah TW; Burkey TH; Ossipov MH; Kovelowski CJ; Sora I; Uhl GR; Zhang X; Rice KC; Roeske WR; Hruby VJ; Yamamura HI; Lai J; Porreca F
Eur J Pharmacol; 2000 Feb; 388(3):241-8. PubMed ID: 10675732
[TBL] [Abstract][Full Text] [Related]
2. Activity of the delta-opioid receptor is partially reduced, whereas activity of the kappa-receptor is maintained in mice lacking the mu-receptor.
Matthes HW; Smadja C; Valverde O; Vonesch JL; Foutz AS; Boudinot E; Denavit-Saubié M; Severini C; Negri L; Roques BP; Maldonado R; Kieffer BL
J Neurosci; 1998 Sep; 18(18):7285-95. PubMed ID: 9736649
[TBL] [Abstract][Full Text] [Related]
3. Mu and Delta opioid receptors activate the same G proteins in human neuroblastoma SH-SY5Y cells.
Alt A; Clark MJ; Woods JH; Traynor JR
Br J Pharmacol; 2002 Jan; 135(1):217-25. PubMed ID: 11786497
[TBL] [Abstract][Full Text] [Related]
4. Modulation of μ-opioid receptor signaling by RGS19 in SH-SY5Y cells.
Wang Q; Traynor JR
Mol Pharmacol; 2013 Feb; 83(2):512-20. PubMed ID: 23197645
[TBL] [Abstract][Full Text] [Related]
5. Identification of 1,3,8-Triazaspiro[4.5]Decane-2,4-Dione Derivatives as a Novel
Meqbil YJ; Aguilar J; Blaine AT; Chen L; Cassell RJ; Pradhan AA; van Rijn RM
J Pharmacol Exp Ther; 2024 May; 389(3):301-309. PubMed ID: 38621994
[No Abstract] [Full Text] [Related]
6. Synthesis, Pharmacology, and Molecular Docking Studies on 6-Desoxo-N-methylmorphinans as Potent μ-Opioid Receptor Agonists.
Dumitrascuta M; Ben Haddou T; Guerrieri E; Noha SM; Schläfer L; Schmidhammer H; Spetea M
J Med Chem; 2017 Nov; 60(22):9407-9412. PubMed ID: 29053268
[TBL] [Abstract][Full Text] [Related]
7. Morphine-induced changes in delta opioid receptor trafficking are linked to somatosensory processing in the rat spinal cord.
Morinville A; Cahill CM; Aibak H; Rymar VV; Pradhan A; Hoffert C; Mennicken F; Stroh T; Sadikot AF; O'Donnell D; Clarke PB; Collier B; Henry JL; Vincent JP; Beaudet A
J Neurosci; 2004 Jun; 24(24):5549-59. PubMed ID: 15201327
[TBL] [Abstract][Full Text] [Related]
8. Agonist-dependent development of delta opioid receptor tolerance in the colon.
DiCello JJ; Saito A; Rajasekhar P; Sebastian BW; McQuade RM; Gondin AB; Veldhuis NA; Canals M; Carbone SE; Poole DP
Cell Mol Life Sci; 2019 Aug; 76(15):3033-3050. PubMed ID: 30904952
[TBL] [Abstract][Full Text] [Related]
9. Reduced nucleus accumbens enkephalins underlie vulnerability to social defeat stress.
Nam H; Chandra R; Francis TC; Dias C; Cheer JF; Lobo MK
Neuropsychopharmacology; 2019 Oct; 44(11):1876-1885. PubMed ID: 31132785
[TBL] [Abstract][Full Text] [Related]
10. SNC 80, a selective, nonpeptidic and systemically active opioid delta agonist.
Bilsky EJ; Calderon SN; Wang T; Bernstein RN; Davis P; Hruby VJ; McNutt RW; Rothman RB; Rice KC; Porreca F
J Pharmacol Exp Ther; 1995 Apr; 273(1):359-66. PubMed ID: 7714789
[TBL] [Abstract][Full Text] [Related]
11. Opioid Analgesia and Opioid-Induced Adverse Effects: A Review.
Paul AK; Smith CM; Rahmatullah M; Nissapatorn V; Wilairatana P; Spetea M; Gueven N; Dietis N
Pharmaceuticals (Basel); 2021 Oct; 14(11):. PubMed ID: 34832873
[TBL] [Abstract][Full Text] [Related]
12. Recent advances on the δ opioid receptor: from trafficking to function.
Gendron L; Mittal N; Beaudry H; Walwyn W
Br J Pharmacol; 2015 Jan; 172(2):403-19. PubMed ID: 24665909
[TBL] [Abstract][Full Text] [Related]
13. Pharmacological traits of delta opioid receptors: pitfalls or opportunities?
van Rijn RM; Defriel JN; Whistler JL
Psychopharmacology (Berl); 2013 Jul; 228(1):1-18. PubMed ID: 23649885
[TBL] [Abstract][Full Text] [Related]
14. Antinociceptive effects of two deltorphins analogs in the tail-immersion test in rats.
Kotlinska JH; Gibula-Bruzda E; Witkowska E; Chung NN; Schiller PW; Izdebski J
Peptides; 2013 Jan; 39():103-10. PubMed ID: 23183627
[TBL] [Abstract][Full Text] [Related]
15. Co-administration of δ- and μ-opioid receptor agonists promotes peripheral opioid receptor function.
Schramm CL; Honda CN
Pain; 2010 Dec; 151(3):763-770. PubMed ID: 20970925
[TBL] [Abstract][Full Text] [Related]
16. Opioid-receptor-heteromer-specific trafficking and pharmacology.
van Rijn RM; Whistler JL; Waldhoer M
Curr Opin Pharmacol; 2010 Feb; 10(1):73-9. PubMed ID: 19846340
[TBL] [Abstract][Full Text] [Related]
17. Pharmacological profiles of alpha 2 adrenergic receptor agonists identified using genetically altered mice and isobolographic analysis.
Fairbanks CA; Stone LS; Wilcox GL
Pharmacol Ther; 2009 Aug; 123(2):224-38. PubMed ID: 19393691
[TBL] [Abstract][Full Text] [Related]
18. Differential noxious and motor tolerance of chronic delta opioid receptor agonists in rodents.
Beaudry H; Proteau-Gagné A; Li S; Dory Y; Chavkin C; Gendron L
Neuroscience; 2009 Jun; 161(2):381-91. PubMed ID: 19328839
[TBL] [Abstract][Full Text] [Related]
19. Essential role of mu opioid receptor in the regulation of delta opioid receptor-mediated antihyperalgesia.
Gendron L; Pintar JE; Chavkin C
Neuroscience; 2007 Dec; 150(4):807-17. PubMed ID: 17997230
[TBL] [Abstract][Full Text] [Related]
20. Spinal G-protein-gated potassium channels contribute in a dose-dependent manner to the analgesic effect of mu- and delta- but not kappa-opioids.
Marker CL; Luján R; Loh HH; Wickman K
J Neurosci; 2005 Apr; 25(14):3551-9. PubMed ID: 15814785
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
